Leukemia Clinical Trials in Miami

Showing 441-460 of 676 trials

Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDS

NCT03459859

The investigators hypothesize that the combination of Pevonedistat/Low-Dose Cytarabine (LDAC) therapy will be tolerable, that a recommended phase 2 dose of Pevonedistat in combination with LDAC will be identified, and that the combination therapy will show evidence of clinical activity in adult patients with Relapsed/Refractory Acute Myelogenous Leukemia (AML) and Advanced Myelodysplastic Syndromes (MDS).

Acute Myelogenous LeukemiaAMLAdvanced Myelodysplastic Syndromes+1 more

Justin Watts, MD12 participantsStarted May 2018

Miami, Florida, United States

COMPLETEDPhase 2< 1 mile

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

NCT00339040

The purpose of this study is to determine the safety of and immune response to a new human papillomavirus (HPV) vaccine in HIV (Human immunodeficiency virus) infected children between the ages of 7 and 12 years.

HIV InfectionsSexually Transmitted Diseases

National Institute of Allergy and Infectious Diseases (NIAID)130 participantsStarted Oct 2006

Alhambra, California, United States • Long Beach, California, United States • Los Angeles, California, United States +31 more locations

Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDS

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

Leukemia Trials in Other Cities

Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC

Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia

A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies

A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission

A Study of LY3023414 in Participants With Advanced Cancer

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Other Conditions in Miami